Correlation Between CureVac NV and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both CureVac NV and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CureVac NV and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CureVac NV and Abcellera Biologics, you can compare the effects of market volatilities on CureVac NV and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CureVac NV with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CureVac NV and Abcellera Biologics.
Diversification Opportunities for CureVac NV and Abcellera Biologics
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between CureVac and Abcellera is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding CureVac NV and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and CureVac NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CureVac NV are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of CureVac NV i.e., CureVac NV and Abcellera Biologics go up and down completely randomly.
Pair Corralation between CureVac NV and Abcellera Biologics
Given the investment horizon of 90 days CureVac NV is expected to under-perform the Abcellera Biologics. But the stock apears to be less risky and, when comparing its historical volatility, CureVac NV is 1.63 times less risky than Abcellera Biologics. The stock trades about -0.06 of its potential returns per unit of risk. The Abcellera Biologics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 278.00 in Abcellera Biologics on August 24, 2024 and sell it today you would lose (6.00) from holding Abcellera Biologics or give up 2.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
CureVac NV vs. Abcellera Biologics
Performance |
| Timeline |
| CureVac NV |
| Abcellera Biologics |
CureVac NV and Abcellera Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CureVac NV and Abcellera Biologics
The main advantage of trading using opposite CureVac NV and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CureVac NV position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.| CureVac NV vs. Willscot Mobile Mini | CureVac NV vs. Fortress Transp Infra | CureVac NV vs. Mesa Air Group | CureVac NV vs. Mayfair Gold Corp |
| Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |